Data Foundry

Drug recalls 2015

Amlodipine besylate and Atorvastatin calcium tablets — Class III drug recall D-1143-2015

Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2015-06-24, distributed nationwide. Subpotent drug

Recall numberD-1143-2015
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmDr. Reddy's Laboratories, Inc., Princeton, NJ, United States
Recall initiated2015-05-06
Classified2015-06-18
Reported by FDA2015-06-24
Terminated2016-03-31
DistributedNationwide (US)
Reason classespotency
NDC43598-0313, 43598-0313-05, 43598-0313-30, 43598-0313-60, 43598-0313-90, 43598-0314, 43598-0314-05, 43598-0314-30, 43598-0314-60, 43598-0314-90, 43598-0315, 43598-0315-05, 43598-0315-30, 43598-0315-60, 43598-0315-90, 43598-0316, 43598-0316-05, 43598-0316-30, 43598-0316-60, 43598-0316-90, 43598-0317, 43598-0317-05, 43598-0317-30, 43598-0317-60, 43598-0317-90 and 30 more
Expiration dates2015-07

Product

Amlodipine besylate and Atorvastatin calcium tablets, 5mg/10mg, packaged in a)30-count bottle (NDC 43598-322-30), b) 90-count bottle (NDC 43598-322-90), Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Bachupally, 500 090 India

Reason for recall

Subpotent drug

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1143-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.